SKP2 and colorectal carcinoma: Using a combination of bioinformatic, genomic, and single-cell quantitative imaging microscopy (QuantIM) approaches, we first determined the clinical impact of SKP2 copy number losses and subsequently determined the impact reduced expression has in CIN, cellular transformation, and CRC pathogenesis.